| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
136,480,000 |
| Market
Cap: |
3.56(B) |
| Last
Volume: |
503,160 |
Avg
Vol: |
501,804 |
| 52
Week Range: |
$25.55 - $39.94 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cohen Gary M |
Director |
– • – |
2009-11-10 |
4 |
OE |
$12.60 |
$62,975 |
D/D |
5,000 |
20,857 |
|
- |
|
| Needham Jeffrey |
Sr. VP Commercial Business Dev |
• – – |
2009-11-10 |
4 |
S |
$38.93 |
$1,667,177 |
D/D |
(42,825) |
10,649 |
|
- |
|
| Needham Jeffrey |
Sr. VP Commercial Business Dev |
• – – |
2009-11-10 |
4 |
OE |
$11.67 |
$499,661 |
D/D |
42,825 |
53,474 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2009-11-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,286 |
2,366,250 |
|
- |
|
| Morris Herman Jr |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
14,794 |
|
- |
|
| Cohen Gary M |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
15,857 |
|
- |
|
| Zilberfarb Ben-Zion |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
6,356 |
|
- |
|
| Hoffing Ellen Randi |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
3,298 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
15,099 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
5,115 |
|
- |
|
| Brlas Laurie |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
15,428 |
|
- |
|
| Kunkle Gary K Jr |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
19,901 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
105,051 |
|
- |
|
| Yu Louis |
Senior VP Global Quality |
• – – |
2009-11-09 |
4 |
S |
$39.58 |
$34,197 |
D/D |
(864) |
865 |
|
- |
|
| Gottfried Ran |
Director |
– • – |
2009-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,514 |
8,856 |
|
- |
|
| Yu Louis |
Senior VP Global Quality |
• – – |
2009-11-06 |
4 |
D |
$39.18 |
$30,208 |
D/D |
(771) |
1,729 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2009-11-05 |
4 |
S |
$38.36 |
$867,291 |
D/D |
(22,593) |
2,953 |
|
- |
|
| Hendrickson John T |
EVP Global Operations & Supply |
• – – |
2009-11-05 |
4 |
OE |
$14.69 |
$341,594 |
D/D |
22,593 |
15,393 |
|
- |
|
| Stewart Michael Robert |
Sr. VP Global Human Resources |
• – – |
2009-11-05 |
4 |
S |
$38.50 |
$673,484 |
D/D |
(17,493) |
7,526 |
|
- |
|
| Stewart Michael Robert |
Sr. VP Global Human Resources |
• – – |
2009-11-05 |
4 |
OE |
$14.69 |
$321,366 |
D/D |
17,493 |
10,648 |
|
- |
|
| Kochan Sharon |
Executive VP U.S. Generics |
• – – |
2009-11-05 |
4 |
S |
$38.18 |
$286,350 |
D/D |
(7,500) |
16 |
|
- |
|
| Kochan Sharon |
Executive VP U.S. Generics |
• – – |
2009-11-05 |
4 |
OE |
$14.69 |
$112,125 |
D/D |
7,500 |
18,093 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2009-11-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,650 |
2,502,636 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2009-10-05 |
4 |
AS |
$34.01 |
$935,759 |
I/I |
(27,516) |
6,722,824 |
|
- |
|
| Arkin Moshe |
Director |
– • – |
2009-10-01 |
4 |
AS |
$34.13 |
$8,015,762 |
I/I |
(234,890) |
6,750,340 |
|
- |
|
1400 Records found
|
|
Page 31 of 56 |
|
|
0.34 (1.32%) 
